Trusted Price Intelligence for Payers

By combining one of the largest medical and pharmaceutical claims datasets in the U.S. with real-time price transparency insights from Payerset, we are able to deliver unparalleled clarity on negotiated rates, remittance rates, historical pricing trends, and payer coverage policies.

PurpleLab’s Trusted Price Intelligence provides insights into contracted rates across all payers, health plans, and care delivery organizations, while providing real-world clinical insights into the claims volume, service-line categorization, and provider hierarchies.

Network Optimization

Optimize networks by benchmarking rates and analyzing service line performance across markets to ensure coverage and cost-effectiveness. Expand benchmarking approach beyond Medicare reference-based pricing (RBP) strategies

Contracting

Compare actual reimbursement rates across providers to identify pricing trends and outliers. Negotiate fairer rates, address outlier pricing that may be driving up costs, and identify early intervention opportunities for high-cost members.

Strategic Planning

Stay ahead of dynamic and competitive market conditions with up-to-date and actionable pricing data and utilization trends.

Rate Explorer

Rate Explorer is the only self-service platform that provides real-time exploration of contracted rates across all payers, health plans, care delivery organizations, and services. Accurately conduct analyses to surface actionable pricing insights to inform healthcare pricing and strategy to increase overall financial viability.

Features and benefits

Comprehensive MRF Coverage

Enhanced Claims Data

Easy-to-use

Real-Time Discovery

All Payer MRF data and hospital MRF data is refreshed quarterly and enhanced with provider data for easy exploration.

Adding color to the standard MRFs, Trusted Price Intelligence integrates claims volumetrics data, clinical service line categorization, HCO and HCP hierarchies, standardized payer rates and remit data.

Easily navigate, understand, and benchmark healthcare pricing data paired with clinical insights. Surface actionable pricing insights to inform healthcare pricing and strategy to increase overall financial viability.

Discover business ready insights through real-time data discovery across all contract reimbursement rates.

Highlighted resources

News

Roche Diagnostics Links PurpleLab and Labcorp Data for ISPOR Research Poster

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Articles

5 Steps For Creating a Targeted HCP and DTC Marketing Strategy

Creating a holistic direct to consumer (DTC) and healthcare provider (HCP) marketing strategy from scratch is a demanding task, especially if you don’t have the clinical expertise to precisely identify the consumers or providers you should be targeting. We’re here to give you 5 simple steps to creating a holistic DTC and HCP targeting strategy…

Articles

Turning price transparency into strategic advantage — 4 takeaways

During a June 9 webinar hosted by Becker’s Payer Issues in collaboration with PurpleLab, leaders from Payerset, PurpleLab and Forvis Mazars outlined how health systems can use price transparency data to improve contract negotiations, support market expansion strategies and prepare for upcoming changes in drug pricing rules. Four Key Takeaways: 1.Price transparency data as…

Videos

Webinar: Navigating Price Transparency: Your Roadmap to Stronger Contracts and Sustainable Growth

Price transparency mandates have introduced an unprecedented volume of data — but turning that data into actionable strategy remains a challenge. Health systems and payers alike are still navigating how to translate pricing insights into stronger contract terms, smarter network expansion and more aligned pricing strategies.

Articles

GLP-1s and The Payer Predicament

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications frequently used to treat type 2 diabetes mellitus (T2DM) and obesity.[1] This class of medications assists in lowering blood sugar levels and promotes weight loss. In addition to treating diabetics, these medications are also used to treat obesity in diabetics as well as non-diabetics. GLP-1 drugs…

Get In Touch

Questions? Ready for a demo or free trial of our healthcare analytics platform, HealthNexus®?
Contact us to get started.